In-silico driven engineering of enantioselectivity of a penicillin G acylase towards active pharmaceutical ingredients
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11310%2F16%3A10368393" target="_blank" >RIV/00216208:11310/16:10368393 - isvavai.cz</a>
Alternative codes found
RIV/61388971:_____/16:00483930
Result on the web
<a href="http://dx.doi.org/10.1016/j.molcatb.2016.11.014" target="_blank" >http://dx.doi.org/10.1016/j.molcatb.2016.11.014</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.molcatb.2016.11.014" target="_blank" >10.1016/j.molcatb.2016.11.014</a>
Alternative languages
Result language
angličtina
Original language name
In-silico driven engineering of enantioselectivity of a penicillin G acylase towards active pharmaceutical ingredients
Original language description
Penicillin G acylase is one of the most employed enzymes in the pharmaceutical industry due to its role in the biotransformation of semi-synthetic Beta-lactam antibiotics. Recently, the enantioselectivity of the penicillin G acylase markedly broadened its application potential. In this study, we have evaluated effects of in-silico replacements of acyl-binding subsite residue Phe24Beta of the enzyme from Achromobacter sp. CCM 4824 to seven markedly smaller amino acids on its enantioselectivity towards industrially relevant compounds. Models of the two most promising mutants bearing substitutions PheBeta24Ala and PheBeta24Cys were investigated using molecular docking calculations. The Cys substitution revealed much better enantioselectivity traits with a set of seven substrates. To verify the relevance of in-silico predictions, we constructed a PGA. A + Phe24BetaCys mutant and determined its enantioselectivity in biocatalytic reactions. Since we experimentally confirmed all these predictions, we expanded our in-silico analysis to another set of seven compounds: the prediction suggested increased enantioselectivity for N-phenylacetyl-p-F-α-phenylalanine. The (R)-enantiomer of this substrate is used as a building block in synthesis of important anti-cancer agent Abarelix. The enantioselectivity of PGA. A + Phe24BetaCys mutant towards this substrate was improved by 75percent reaching E-value of about 70. Our results suggest the rapid identification of interesting replacements altering enantioselectivity using in-silico approach as the way for further expanding biotechnological application of penicillin G acylase.
Czech name
—
Czech description
—
Classification
Type
J<sub>SC</sub> - Article in a specialist periodical, which is included in the SCOPUS database
CEP classification
—
OECD FORD branch
10606 - Microbiology
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Molecular Catalysis - B Enzymatic
ISSN
1381-1177
e-ISSN
—
Volume of the periodical
133
Issue of the periodical within the volume
Supplement 1 (November 2016)
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
7
Pages from-to
"S53"-"S59"
UT code for WoS article
—
EID of the result in the Scopus database
2-s2.0-85009773584